Hepatoblastoma occurring in patients with germline antigen-presenting cell mutations have lower grade tumors with higher frequency of fetal histology (a positive prognostic factor), absence of CTNNB1 mutations and better clinical outcomes. Here, CTNNB1 is linked to hepatoblastoma.